ATE488243T1 - Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung - Google Patents

Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung

Info

Publication number
ATE488243T1
ATE488243T1 AT07764311T AT07764311T ATE488243T1 AT E488243 T1 ATE488243 T1 AT E488243T1 AT 07764311 T AT07764311 T AT 07764311T AT 07764311 T AT07764311 T AT 07764311T AT E488243 T1 ATE488243 T1 AT E488243T1
Authority
AT
Austria
Prior art keywords
independently
carbon atoms
group
another
pharmaceutical composition
Prior art date
Application number
AT07764311T
Other languages
English (en)
Inventor
Ales Franc
Petr Sova
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Application granted granted Critical
Publication of ATE488243T1 publication Critical patent/ATE488243T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07764311T 2006-06-20 2007-06-20 Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung ATE488243T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060401A CZ300590B6 (cs) 2006-06-20 2006-06-20 Farmaceutická kompozice pro injekcní podání
PCT/CZ2007/000060 WO2007147373A2 (en) 2006-06-20 2007-06-20 Pharmaceutical composition for injectional, particularly targeted local administration

Publications (1)

Publication Number Publication Date
ATE488243T1 true ATE488243T1 (de) 2010-12-15

Family

ID=38658280

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07764311T ATE488243T1 (de) 2006-06-20 2007-06-20 Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung

Country Status (14)

Country Link
US (1) US20090175947A1 (de)
EP (1) EP2035020B1 (de)
JP (1) JP2009541229A (de)
KR (1) KR20090040299A (de)
CN (1) CN101505765A (de)
AT (1) ATE488243T1 (de)
AU (1) AU2007262496A1 (de)
CZ (1) CZ300590B6 (de)
DE (1) DE602007010625D1 (de)
IL (1) IL196098A0 (de)
PL (1) PL2035020T3 (de)
RU (1) RU2440113C2 (de)
UA (1) UA93405C2 (de)
WO (1) WO2007147373A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
US10457700B2 (en) 2015-03-06 2019-10-29 University Of Georgia Research Foundation, Inc. Platinum prodrugs and methods of making and using thereof
HUE056897T2 (hu) 2015-12-09 2022-03-28 Univ Wien Med Monomaleimid-funkcionalizált platinavegyületek rákterápiához
CN116120376B (zh) * 2023-02-28 2025-09-09 中国科学技术大学 多不饱和脂肪酸与顺铂偶联形成的四价铂前药及制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62207283A (ja) * 1986-03-07 1987-09-11 Yoshinori Kitani 新規な白金錯体
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
US5549910A (en) * 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
FI905018A7 (fi) * 1989-10-17 1991-04-18 Bristol Myers Squibb Co Veteen ja liuottimeen liukenevat aksiaaliset hydroksi- ja mono- ja di-karboksyylihappojohdannaiset, joilla on korkea kasvainaktiivisuus
WO1996026949A1 (en) * 1995-02-28 1996-09-06 Debiopharm Sa Novel platinum (iv) complexes, process for producing the same, and carcinostatic agents containing the same
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
CZ288912B6 (cs) * 1998-05-27 2001-09-12 Lachema, A. S. Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
KR100317473B1 (ko) * 1999-05-11 2001-12-22 이계호 신규의 백금(ｉｖ)착제 및 그 제조방법
EP1253921A4 (de) * 2000-01-28 2004-10-13 Merck & Co Inc Behandlung und prophylaxe des prostatakrebs mit cox-2 selektiven inhibitoren
CA2326004A1 (en) * 2000-11-02 2002-05-02 Richard E. Jones Methods for treating cellular proliferative disorders
WO2004047800A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
UA80872C2 (uk) * 2003-03-31 2007-11-12 Пліва-Лахема А.С. Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення
CZ296169B6 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
EP1811963A4 (de) * 2004-11-08 2010-01-06 Transave Inc Verfahren zur krebsbehandlung mit intraperitoneal verabreichten platinverbindungsformulierungen auf lipidbasis
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
WO2007147373A2 (en) 2007-12-27
JP2009541229A (ja) 2009-11-26
WO2007147373B1 (en) 2008-05-15
EP2035020B1 (de) 2010-11-17
KR20090040299A (ko) 2009-04-23
CZ2006401A3 (cs) 2007-12-27
CN101505765A (zh) 2009-08-12
RU2009101493A (ru) 2010-07-27
RU2440113C2 (ru) 2012-01-20
US20090175947A1 (en) 2009-07-09
WO2007147373A3 (en) 2008-03-13
AU2007262496A1 (en) 2007-12-27
DE602007010625D1 (de) 2010-12-30
CZ300590B6 (cs) 2009-06-24
EP2035020A2 (de) 2009-03-18
IL196098A0 (en) 2009-09-01
PL2035020T3 (pl) 2011-05-31
UA93405C2 (ru) 2011-02-10

Similar Documents

Publication Publication Date Title
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
DE60228857D1 (de) Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
DE60218193D1 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
DE602007010625D1 (de) Pharmazeutische zusammensetzung zur injektion, insbesondere zur gezielten lokalen anwendung
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
DE602005025382D1 (de) Orale pharmazeutische zusammensetzung für den gezierwendung als medikament
GEP20115240B (en) Indole derivatives, process for their preparation and pharmaceutical compositions containing them
ATE478655T1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung
TW200635925A (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
RU2009101495A (ru) Фармацевтическая композиция для введения инъекций
GEP20115192B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
DE60326731D1 (de) Arzneizubereitung und deren anwendung zur behandlu
ATE451385T1 (de) Verbindungen zur inhibierung von apoptose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties